Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	Manufacturers	Review Status	Status Date	View
JYSZ2200060	纳武利尤单抗注射液	nivolumab	Injection	Biological Products	License Renew	2022-11-04		Bristol-Myers Squibb Pharma Eeig;Bristol-Myers Squibb Holdings Pharma Ltd Liability Company;BRISTOL-MYERS Squibb (CHINA) Co Ltd			view
JYSZ2200059	纳武利尤单抗注射液	nivolumab	Injection	Biological Products	License Renew	2022-11-04		Bristol-Myers Squibb Pharma Eeig;Bristol-Myers Squibb Holdings Pharma Ltd Liability Company;BRISTOL-MYERS Squibb (CHINA) Co Ltd			view
JYSB2300219	纳武利尤单抗注射液	nivolumab	Injection	Biological Products	Supplementary Application	2023-12-20		Bristol-Myers Squibb Pharma Eeig;Bristol-Myers Squibb Holdings Pharma Ltd Liability Company			view
JYSB2300218	纳武利尤单抗注射液	nivolumab	Injection	Biological Products	Supplementary Application	2023-12-20		Bristol-Myers Squibb Pharma Eeig;Bristol-Myers Squibb Holdings Pharma Ltd Liability Company			view
JYSB2300210	纳武利尤单抗注射液	nivolumab	Injection	Biological Products	Supplementary Application	2023-12-09		Bristol-Myers Squibb Pharma Eeig;Bristol-Myers Squibb Holdings Pharma Ltd Liability Company			view
JYSB2300209	纳武利尤单抗注射液	nivolumab	Injection	Biological Products	Supplementary Application	2023-12-09		Bristol-Myers Squibb Pharma Eeig;Bristol-Myers Squibb Holdings Pharma Ltd Liability Company			view
JYSB2300067	纳武利尤单抗注射液	nivolumab	Injection	Biological Products	Supplementary Application	2023-04-19		Vetter Pharma-Fertigung Gmbh & Co KG;Bristol-Myers Squibb Pharma Eeig			view
JYSB2200075	纳武利尤单抗注射液	nivolumab	Injection	Biological Products	Supplementary Application	2022-04-24		Bristol-Myers Squibb Pharma Eeig;Bristol-Myers Squibb Holdings Pharma Ltd Liability Company			view
JYSB2200074	纳武利尤单抗注射液	nivolumab	Injection	Biological Products	Supplementary Application	2022-04-24		Bristol-Myers Squibb Pharma Eeig;Bristol-Myers Squibb Holdings Pharma Ltd Liability Company			view
JYSB2101136	纳武利尤单抗注射液	nivolumab	Injection	Biological Products	Supplementary Application	2021-09-15		Bristol-Myers Squibb Pharma Eeig;Bristol-Myers Squibb Holdings Pharma Ltd Liability Company			view
JYSB2101135	纳武利尤单抗注射液	nivolumab	Injection	Biological Products	Supplementary Application	2021-09-15		Bristol-Myers Squibb Pharma Eeig;Bristol-Myers Squibb Holdings Pharma Ltd Liability Company			view
JYSB2100071	纳武利尤单抗注射液	nivolumab	Injection	Biological Products	Supplementary Application	2021-03-11	百时美施贵宝（中国）投资有限公司	BRISTOL-MYERS Squibb (CHINA) Co Ltd;Bristol-Myers Squibb Pharma Eeig;Bristol-Myers Squibb Holdings Pharma Ltd Liability Company	Certificate Issued	2021-11-18	view
JYSB2100070	纳武利尤单抗注射液	nivolumab	Injection	Biological Products	Supplementary Application	2021-03-11	百时美施贵宝（中国）投资有限公司	BRISTOL-MYERS Squibb (CHINA) Co Ltd;Bristol-Myers Squibb Pharma Eeig;Bristol-Myers Squibb Holdings Pharma Ltd Liability Company	Certificate Issued	2021-11-18	view
JYSB2000330	纳武利尤单抗注射液	nivolumab	Injection	Biological Products	Supplementary Application	2020-07-04		Bristol-Myers Squibb Pharma Eeig;Bristol-Myers Squibb Holdings Pharma Ltd Liability Company	Certificate Issued	2020-08-07	view
JYSB2000329	纳武利尤单抗注射液	nivolumab	Injection	Biological Products	Supplementary Application	2020-07-04		Bristol-Myers Squibb Pharma Eeig;Bristol-Myers Squibb Holdings Pharma Ltd Liability Company	Certificate Issued	2020-08-07	view
JYSB2000328	纳武利尤单抗注射液	nivolumab	Injection	Biological Products	Supplementary Application	2020-07-04		Bristol-Myers Squibb Pharma Eeig;Bristol-Myers Squibb Holdings Pharma Ltd Liability Company	Certificate Issued	2020-08-11	view
JYSB2000327	纳武利尤单抗注射液	nivolumab	Injection	Biological Products	Supplementary Application	2020-07-04		Bristol-Myers Squibb Pharma Eeig;Bristol-Myers Squibb Holdings Pharma Ltd Liability Company	Certificate Issued	2020-08-11	view
JYSB2000282	纳武利尤单抗注射液	nivolumab	Injection	Biological Products	Supplementary Application	2020-06-30		Bristol-Myers Squibb Holdings Pharma Ltd Liability Company;Bristol-Myers Squibb Company	In Review	2020-06-29	view
JYSB2000104	纳武利尤单抗注射液	nivolumab	Injection	Biological Products	Supplementary Application	2020-04-09		Bristol-Myers Squibb Pharma Eeig;Bristol-Myers Squibb Holdings Pharma Ltd Liability Company	Certificate Issued	2020-12-30	view
JYSB2000103	纳武利尤单抗注射液	nivolumab	Injection	Biological Products	Supplementary Application	2020-04-09		Bristol-Myers Squibb Pharma Eeig;Bristol-Myers Squibb Holdings Pharma Ltd Liability Company	Certificate Issued	2020-12-30	view